Literature DB >> 31221820

REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics.

R L Carhart-Harris1, K J Friston2.   

Abstract

This paper formulates the action of psychedelics by integrating the free-energy principle and entropic brain hypothesis. We call this formulation relaxed beliefs under psychedelics (REBUS) and the anarchic brain, founded on the principle that-via their entropic effect on spontaneous cortical activity-psychedelics work to relax the precision of high-level priors or beliefs, thereby liberating bottom-up information flow, particularly via intrinsic sources such as the limbic system. We assemble evidence for this model and show how it can explain a broad range of phenomena associated with the psychedelic experience. With regard to their potential therapeutic use, we propose that psychedelics work to relax the precision weighting of pathologically overweighted priors underpinning various expressions of mental illness. We propose that this process entails an increased sensitization of high-level priors to bottom-up signaling (stemming from intrinsic sources), and that this heightened sensitivity enables the potential revision and deweighting of overweighted priors. We end by discussing further implications of the model, such as that psychedelics can bring about the revision of other heavily weighted high-level priors, not directly related to mental health, such as those underlying partisan and/or overly-confident political, religious, and/or philosophical perspectives. SIGNIFICANCE STATEMENT: Psychedelics are capturing interest, with efforts underway to bring psilocybin therapy to marketing authorisation and legal access within a decade, spearheaded by the findings of a series of phase 2 trials. In this climate, a compelling unified model of how psychedelics alter brain function to alter consciousness would have appeal. Towards this end, we have sought to integrate a leading model of global brain function, hierarchical predictive coding, with an often-cited model of the acute action of psychedelics, the entropic brain hypothesis. The resulting synthesis states that psychedelics work to relax high-level priors, sensitising them to liberated bottom-up information flow, which, with the right intention, care provision and context, can help guide and cultivate the revision of entrenched pathological priors.
Copyright © 2019 The Author(s).

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31221820      PMCID: PMC6588209          DOI: 10.1124/pr.118.017160

Source DB:  PubMed          Journal:  Pharmacol Rev        ISSN: 0031-6997            Impact factor:   25.468


  230 in total

1.  What geometric visual hallucinations tell us about the visual cortex.

Authors:  Paul C Bressloff; Jack D Cowan; Martin Golubitsky; Peter J Thomas; Matthew C Wiener
Journal:  Neural Comput       Date:  2002-03       Impact factor: 2.026

2.  Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers.

Authors:  Rainer Kraehenmann; Katrin H Preller; Milan Scheidegger; Thomas Pokorny; Oliver G Bosch; Erich Seifritz; Franz X Vollenweider
Journal:  Biol Psychiatry       Date:  2014-04-26       Impact factor: 13.382

3.  5-Hydroxytryptamine2A serotonin receptors in the primate cerebral cortex: possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites.

Authors:  R L Jakab; P S Goldman-Rakic
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-20       Impact factor: 11.205

Review 4.  Peak experiences and the afterglow phenomenon: when and how do therapeutic effects of hallucinogens depend on psychedelic experiences?

Authors:  Tomislav Majić; Timo T Schmidt; Jürgen Gallinat
Journal:  J Psychopharmacol       Date:  2015-02-09       Impact factor: 4.153

5.  A hierarchy of intrinsic timescales across primate cortex.

Authors:  John D Murray; Alberto Bernacchia; David J Freedman; Ranulfo Romo; Jonathan D Wallis; Xinying Cai; Camillo Padoa-Schioppa; Tatiana Pasternak; Hyojung Seo; Daeyeol Lee; Xiao-Jing Wang
Journal:  Nat Neurosci       Date:  2014-11-10       Impact factor: 24.884

6.  Assessing the Psychedelic "After-Glow" in Ayahuasca Users: Post-Acute Neurometabolic and Functional Connectivity Changes Are Associated with Enhanced Mindfulness Capacities.

Authors:  Frederic Sampedro; Mario de la Fuente Revenga; Marta Valle; Natalia Roberto; Elisabet Domínguez-Clavé; Matilde Elices; Luís Eduardo Luna; José Alexandre S Crippa; Jaime E C Hallak; Draulio B de Araujo; Pablo Friedlander; Steven A Barker; Enrique Álvarez; Joaquim Soler; Juan C Pascual; Amanda Feilding; Jordi Riba
Journal:  Int J Neuropsychopharmacol       Date:  2017-09-01       Impact factor: 5.176

7.  Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial.

Authors:  Roland R Griffiths; Matthew W Johnson; Michael A Carducci; Annie Umbricht; William A Richards; Brian D Richards; Mary P Cosimano; Margaret A Klinedinst
Journal:  J Psychopharmacol       Date:  2016-12       Impact factor: 4.153

8.  Am I Self-Conscious? (Or Does Self-Organization Entail Self-Consciousness?).

Authors:  Karl Friston
Journal:  Front Psychol       Date:  2018-04-24

9.  Deep temporal models and active inference.

Authors:  Karl J Friston; Richard Rosch; Thomas Parr; Cathy Price; Howard Bowman
Journal:  Neurosci Biobehav Rev       Date:  2018-05-08       Impact factor: 8.989

10.  Psychedelics Promote Structural and Functional Neural Plasticity.

Authors:  Calvin Ly; Alexandra C Greb; Lindsay P Cameron; Jonathan M Wong; Eden V Barragan; Paige C Wilson; Kyle F Burbach; Sina Soltanzadeh Zarandi; Alexander Sood; Michael R Paddy; Whitney C Duim; Megan Y Dennis; A Kimberley McAllister; Kassandra M Ori-McKenney; John A Gray; David E Olson
Journal:  Cell Rep       Date:  2018-06-12       Impact factor: 9.423

View more
  82 in total

Review 1.  The acute effects of classic psychedelics on memory in humans.

Authors:  C J Healy
Journal:  Psychopharmacology (Berl)       Date:  2021-01-09       Impact factor: 4.530

2.  Psilocybin Therapeutic Research: The Present and Future Paradigm.

Authors:  Robert B Kargbo
Journal:  ACS Med Chem Lett       Date:  2020-03-02       Impact factor: 4.345

Review 3.  Do psychedelics change beliefs?

Authors:  H T McGovern; P Leptourgos; B T Hutchinson; P R Corlett
Journal:  Psychopharmacology (Berl)       Date:  2022-05-04       Impact factor: 4.530

Review 4.  Forms of prediction in the nervous system.

Authors:  Christoph Teufel; Paul C Fletcher
Journal:  Nat Rev Neurosci       Date:  2020-03-10       Impact factor: 34.870

5.  Rapid and sustained decreases in suicidality following a single dose of ayahuasca among individuals with recurrent major depressive disorder: results from an open-label trial.

Authors:  Richard J Zeifman; Nikhita Singhal; Rafael G Dos Santos; Rafael F Sanches; Flávia de Lima Osório; Jaime E C Hallak; Cory R Weissman
Journal:  Psychopharmacology (Berl)       Date:  2020-10-29       Impact factor: 4.530

6.  Optogenetic Activation of Afferent Pathways in Brain Slices and Modulation of Responses by Volatile Anesthetics.

Authors:  Caitlin A Murphy; Aeyal Raz; Sean M Grady; Matthew I Banks
Journal:  J Vis Exp       Date:  2020-07-23       Impact factor: 1.355

Review 7.  On the Relationship between Classic Psychedelics and Suicidality: A Systematic Review.

Authors:  Richard J Zeifman; Nikhita Singhal; Leah Breslow; Cory R Weissman
Journal:  ACS Pharmacol Transl Sci       Date:  2021-03-11

Review 8.  Neuromodulation of the mind-wandering brain state: the interaction between neuromodulatory tone, sharp wave-ripples and spontaneous thought.

Authors:  Claire O'Callaghan; Ishan C Walpola; James M Shine
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2020-12-14       Impact factor: 6.237

Review 9.  Ketamine and Serotonergic Psychedelics: Common Mechanisms Underlying the Effects of Rapid-Acting Antidepressants.

Authors:  Bashkim Kadriu; Maximillian Greenwald; Ioline D Henter; Jessica R Gilbert; Christoph Kraus; Lawrence T Park; Carlos A Zarate
Journal:  Int J Neuropsychopharmacol       Date:  2021-01-20       Impact factor: 5.176

10.  Relational Processes in Ayahuasca Groups of Palestinians and Israelis.

Authors:  Leor Roseman; Yiftach Ron; Antwan Saca; Natalie Ginsberg; Lisa Luan; Nadeem Karkabi; Rick Doblin; Robin Carhart-Harris
Journal:  Front Pharmacol       Date:  2021-05-19       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.